Impacts of the COVID-19 pandemic on healthcare access among patients receiving medication for opioid use disorder.

ABSTRACT:

Background

The COVID-19 pandemic significantly altered treatment delivery for opioid treatment programs (OTPs) dispensing medications for opioid use disorder (MOUD). We aimed to identify patterns of substance use among MOUD patients and examine whether COVID-19-related impacts on access to healthcare varied across subgroups.

Methods

This analysis was embedded within a type 3 hybrid trial that enrolled patients across eight OTPs at the start of the pandemic. Enrolled patients reported on past-30 day use of multiple substances during their baseline assessment. Participants re-contacted in May-July 2020 completed a survey about COVID-19-related impacts on various life domains. Using latent class analysis we identified patient subgroups, and then examined group differences on a

SUBMITTER: Jacka BP 

PROVIDER: S-EPMC7883735 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature